CORCEPT THERAPEUTICS INC (CORT) Free cash flow 2016–2025
CORCEPT THERAPEUTICS INC (CORT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$141.8MFY2025 · since FY2016: $18.2M → $141.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $141.8M | -27.7% |
| FY2024 | $196.1M | +55.0% |
| FY2023 | $126.5M | +5.5% |
| FY2022 | $119.9M | -28.4% |
| FY2021 | $167.4M | +11.1% |
| FY2020 | $150.7M | +11.6% |
| FY2019 | $135.0M | +17.0% |
| FY2018 | $115.4M | +90.6% |
| FY2017 | $60.5M | +232.6% |
| FY2016 | $18.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice